Dr Reddys Drug Patent Portfolio

Dr Reddys owns 1 orange book drug protected by 1 US patent Given below is the list of Dr Reddys's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10993952 Stable ready to use cyclophosphamide liquid formulations 15 Feb, 2036
Active


Given below is the list of recent legal activities going on the following drug patents of Dr Reddys.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 30 May, 2024 US10849916
Payment of Maintenance Fee, 4th Yr, Small Entity 08 May, 2024 US10993952 (Litigated)
Recordation of Patent Grant Mailed 12 Jul, 2022 US11382923
Patent Issue Date Used in PTA Calculation 12 Jul, 2022 US11382923
Email Notification 23 Jun, 2022 US11382923
Issue Notification Mailed 22 Jun, 2022 US11382923
Dispatch to FDC 08 Jun, 2022 US11382923
Application Is Considered Ready for Issue 08 Jun, 2022 US11382923
Issue Fee Payment Received 06 Jun, 2022 US11382923
Issue Fee Payment Verified 06 Jun, 2022 US11382923
Letter Accepting Correction of Inventorship Under Rule 1.48 06 May, 2022 US11382923
Email Notification 06 May, 2022 US11382923
Filing Receipt - Updated 06 May, 2022 US11382923
Miscellaneous Incoming Letter 03 May, 2022 US11382923
Email Notification 25 Apr, 2022 US11382923


Dr Reddys's Family Patents

Dr Reddys drugs have patent protection in a total of 3 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Dr Reddys Drug List

Given below is the complete list of Dr Reddys's drugs and the patents protecting them.


1. Cyclophosphamide

Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10993952 Stable ready to use cyclophosphamide liquid formulations 15 Feb, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List